Genetic polymorphisms in serine protease inhibitor Kazal-type 5 and risk of atopic dermatitis: A meta-analysis

BACKGROUND: This study aimed to investigate the role of serine protease inhibitor Kazal-type 5 (SPINK5) polymorphisms (Asn368Ser, Asp386Asn and Glu420Lys) and the risk of atopic dermatitis (AD). METHODS: Studies associated with SPINK5 mutations and AD risk were searched from three databases, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yunling, Li, Yin, Li, Wei, Guo, Xiaoxuan, Zhou, Sha, Zheng, Huiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360313/
https://www.ncbi.nlm.nih.gov/pubmed/32664181
http://dx.doi.org/10.1097/MD.0000000000021256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360313/
https://www.ncbi.nlm.nih.gov/pubmed/32664181
http://dx.doi.org/10.1097/MD.0000000000021256

Ejemplares similares